# Exploration of Neuroimaging and Biochemical Prognostic Indicators for POCD

> **NCT02164669** · — · UNKNOWN · sponsor: **wangqiang** · enrollment: 20 (estimated)

## Conditions studied

- Postoperative Cognitive Dysfunction
- Cognitive Impairment

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02164669
- **Lead sponsor:** wangqiang
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-05
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2014-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02164669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02164669, "Exploration of Neuroimaging and Biochemical Prognostic Indicators for POCD". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02164669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*